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Evidence from industrialized countries indi-
cates that acute exposure to airborne pollu-
tants, such as solid particulate matter (PM), is
associated with an increased risk of morbidity
and mortality (Dockery 2001; Fairley 1990;
Samet et al. 2000a, 2000b). The collective
implication of this evidence is that PM affects
tissues and organs outside the respiratory tract,
as evidenced by the occurrence of cardio-
vascular dysfunction on high pollution days
(Goldberg et al. 2000, 2001; Samet et al.
2000a). Although the epidemiologic evidence
is convincing, the biologic mechanisms by
which PM evokes systemic effects remain to
be deﬁned.
Only recently have scientists started to rec-
ognize that the systemic effects of PM may be
as important as the pulmonary effects. Despite
its obvious importance in regulating the con-
vective delivery of cells and molecules to all tis-
sues, and in the etiology of most cardiovascular
diseases, no research has investigated how sys-
temic microvascular function is affected by
pulmonary PM exposure. However, the fol-
lowing results suggest that systemic micro-
vascular effects of pulmonary PM exposure are
possible. Constriction of the brachial artery
has been observed in humans exposed to PM
and ozone (Brook et al. 2002). PM elicits
vasorelaxation in aortic rings that had been
precontracted with phenylephrine but has no
effect on small isolated arteries (Bagate et al.
2004; Knaapen et al. 2001). Although intrigu-
ing, conclusions from these latter ﬁndings are
limited, because isolation of any tissue and
subsequent exposure to PM in vitro assumes
that PM must access the systemic circulation
and interact directly with the vasculature.
Endothelial products can have potent
effects on microvascular smooth muscle tone.
Ulrich et al. (2002) found that pulmonary
exposure to PM caused a 60% decrease in
endothelin-1 and angiotensin-converting
enzyme mRNA levels in lung tissue. They
interpreted this result as an indication of pos-
sible endothelial damage in pulmonary blood
vessels. However, the effect of pulmonary
exposure to PM on endothelial cell function
in the systemic microcirculation has not been
evaluated.
Although several investigations have docu-
mented systemic responses to PM exposure,
the underlying mechanisms of action remain
unclear. However, inﬂammation appears to be
a common denominator in the studies that
report a systemic effect of PM exposure
(Gardner et al. 2000; Moyer et al. 2002; Salvi
et al. 1999; Tan et al. 2000; van Eeden et al.
2001). Cultured human alveolar macrophages
(AMs) produce tumor necrosis factor (TNF-α)
and proinflammatory cytokines such as 
granulocyte-macrophage colony-stimulating
factor, interleukin-6 (IL-6), and IL-1 after
phagocytosing PM. Additionally, circulating
IL-1 is elevated in humans exposed to PM
(van Eeden et al. 2001). Pulmonary produc-
tion of such mediators may induce systemic
responses. Indeed, TNF-α, IL-6, and IL-1 can
stimulate microvascular dilation, alter leuko-
cyte dynamics and increase microvascular
permeability (Baudry et al. 1996; Brian and
Faraci 1998; Kunkel et al. 1998; Matsuki and
Duling 2000; Vicaut et al. 1991). Acute
exposure to PM accelerates the transit of
polymorphonuclear leukocytes (PMNLs)
from bone marrow, whereas chronic exposure
increases the size of the bone marrow PMNL
pool (van Eeden and Hogg 2002). Blood
samples from healthy humans exposed to PM
reveal a systemic inflammatory response in
the form of elevated immature PMNL (Tan
et al. 2000), neutrophils, and platelets (Salvi
et al. 1999). In addition to elevating circulat-
ing PMNLs, PM exposure has also been
shown to accelerate the formation of athero-
sclerotic lesions and increase plaque cell
turnover (Suwa et al. 2002). Collectively,
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Acute exposure to airborne pollutants, such as solid particulate matter (PM), increases the risk of
cardiovascular dysfunction, but the mechanisms by which PM evokes systemic effects remain to be
identiﬁed. The purpose of this study was to determine if pulmonary exposure to a PM surrogate,
such as residual oil ﬂy ash (ROFA), affects endothelium-dependent dilation in the systemic micro-
circulation. Rats were intratracheally instilled with ROFA at 0.1, 0.25, 1 or 2 mg/rat 24 hr before
experimental measurements. Rats intratracheally instilled with saline or titanium dioxide
(0.25 mg/rat) served as vehicle or particle control groups, respectively. In vivo microscopy of the
spinotrapezius muscle was used to study systemic arteriolar dilator responses to the Ca2+
ionophore A23187, administered by ejection via pressurized micropipette into the arteriolar
lumen. We used analysis of bronchoalveolar lavage (BAL) samples to monitor identified pul-
monary inﬂammation and damage. To determine if ROFA exposure affected arteriolar nitric oxide
sensitivity, sodium nitroprusside was iontophoretically applied to arterioles of rats exposed to
ROFA. In saline-treated rats, A23187 dilated arterioles up to 72 ± 7% of maximum. In ROFA-
and TiO2-exposed rats, A23187-induced dilation was signiﬁcantly attenuated. BAL ﬂuid analysis
revealed measurable pulmonary inflammation and damage after exposure to 1 and 2 mg ROFA
(but not TiO2 or < 1 mg ROFA), as evidenced by signiﬁcantly higher polymorphonuclear leuko-
cyte cell counts, enhanced BAL albumin levels, and increased lactate dehydrogenase activity in
BAL fluid. The sensitivity of arteriolar smooth muscle to NO was similar in saline-treated and
ROFA-exposed rats, suggesting that pulmonary exposure to ROFA affected endothelial rather
than smooth muscle function. A signiﬁcant increase in venular leukocyte adhesion and rolling was
observed in ROFA-exposed rats, suggesting local inﬂammation at the systemic microvascular level.
These results indicate that pulmonary PM exposure impairs systemic endothelium-dependent
arteriolar dilation. Moreover, because rats exposed to < 1 mg ROFA or TiO2 did not exhibit BAL
signs of pulmonary damage or inflammation, it appears that PM exposure can impair systemic
microvascular function independently of detectable pulmonary inﬂammation. Key words: arteriole,
endothelium, nitric oxide, particulate matter, residual oil ﬂy ash, ROFA, spinotrapezius muscle,
systemic microcirculation, titanium dioxide. Environ Health Perspect 112:1299–1306 (2004).
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with PM exposure have been proposed to be
linked to cardiovascular dysfunction in com-
promised individuals. However, specific
changes and/or effects of PM exposure at the
systemic microvascular level, where the major-
ity of peripheral resistance resides (Renkin
1984; Zweifach et al. 1981; Zweifach and
Lipowsky 1984) and vascular dysfunction can
be lethal, have not been evaluated.
Microvascular resistance is responsible for
the largest dissipation of pressure across the
systemic circulation (Renkin 1984; Zweifach
et al. 1981; Zweifach and Lipowsky 1984).
The resistance of a given microvascular net-
work is a function of network branching pat-
terns, vessel anatomy, and vessel density
(Zweifach et al. 1981). Because arteriolar resis-
tance is a highly dynamic state that is chieﬂy
determined by internal vascular diameter, it is
acutely dependent on a delicate balance
between local, humoral, and neural stimuli, as
well as the microvascular wall anatomy.
Disruption, impairment, or imbalance of these
stimuli, often accompanied by changes in wall
structure, have been well characterized in
cardiovascular diseases such as hypertension
and ischemia, with myocardial infarction and
stroke being the most lethal (Baumbach et al.
2002; Hein et al. 2003; Prewitt et al. 2002;
Schwartzkopff et al. 1992, 1998; Suzuki et al.
1994).
Based on the prevalence of cardiovascular
dysfunction on high pollution days, we hypoth-
esized that impairment of normal microvascular
endothelial cell function constitutes an impor-
tant component of the systemic effects associ-
ated with pulmonary PM exposure. The
purpose of this study was to determine the
effects of pulmonary PM exposure on systemic
endothelium-dependent arteriolar dilation.
Intratracheal (IT) instillation and broncho-
alveolar lavage (BAL) were used in conjunction
with intravital microscopy to study the effects
of residual oil fly ash (ROFA) exposure on
microvascular function in the rat spinotrapezius
muscle. The spinotrapezius muscle preparation
has been used for > 30 years as an experimental
model to evaluate physiologic and pathophysio-
logic phenomena within the microcirculation
(Bailey et al. 2000; Gray 1973). This prepara-
tion has been an essential tool in the funda-
mental understanding of capillary network
development (Skalak and Schmid-Schonbein
1986); neurogenic, humoral, and myogenic
control of microvascular resistance (Lash and
Shoukas 1991; Nakamura and Prewitt 1991;
Nurkiewicz and Boegehold 1998); and the
physiologic roles of oxygen, nitric oxide, and
calcium (Ca2+) in microcirculation (Linderman
and Boegehold 1999; Pries et al. 1995; Toth
et al. 1998). Additionally, the spinotrapezius
muscle preparation has been extensively used to
characterize pathophysiologic microvascular
consequences of chronic diseases such as dia-
betes (Kindig et al. 1998), hypertension
(Boegehold 1991; Nurkiewicz and Boegehold
1998; Zweifach et al. 1981), and heart failure
(Kindig et al. 1999). Arterioles of the first
branching order were studied because these ves-
sels, together with their upstream feed arteries,
are responsible for approximately 60% of total
spinotrapezius muscle vascular resistance and
therefore are of major importance for local
blood ﬂow regulation (Boegehold 1991).
Experimental Objectives
Objective 1. Our ﬁrst objective was to deter-
mine if pulmonary exposure to PM has an
effect on systemic microvascular function.
Rats were exposed by IT instillation to various
doses of ROFA or saline. At 24 hr post-
exposure, we evaluated systemic microvascular
function by intravital microscopy of arterioles
in the spinotrapezius muscle. Microvascular
function was determined by measurement of
resting arteriolar diameter and tone and by
responsiveness to dilation dependent on the
calcium ionophore A23187.
Objective 2. Our second objective was to
determine if the effects of pulmonary exposure
to PM on systemic microvascular function
were due to modification of endothelial or
smooth muscle function. Rats were exposed to
PM by IT instillation, and arteriolar smooth
muscle sensitivity to NO was determined by
iontophoretically applying the NO donor
sodium nitroprusside (SNP) to the exterior
arteriolar wall and measuring dilation.
Objective 3. Our third objective was to
determine if the effects of pulmonary expo-
sure to PM on systemic microvascular func-
tion were dependent on pulmonary and/or
microvascular inflammation. Rats were
exposed to PM by IT instillation. Pulmonary
inflammation and damage were measured
24 hr postexposure as BAL cell counts and
activity, acellular BAL albumin levels, and
BAL fluid lactate dehydrogenase (LDH)
activity. Microvascular inflammation was
monitored microscopically 24 hr post-
exposure by measuring systemic leukocyte
adhesion and rolling in ﬁrst-order venules of
the spinotrapezius muscle.
Materials and Methods
ROFA preparation. ROFA was collected from
a precipitator at Boston Edison Company
(Mystic Power Plant #4, Everett, MA). ROFA
particle size and elemental composition from
this source have been previously characterized
(Antonini et al. 2002; Roberts et al. 2004).
ROFA particles were of respirable size with a
count mean diameter of 2.2 µm (as determined
by scanning electron microscopy (JSM 5600
SEM; JEOL Ltd., Peabody, MA). The major
metal contaminants were iron, aluminum,
vanadium, nickel, calcium, and zinc. The
main soluble metals were aluminum, nickel,
and calcium. Vanadium comprised < 1% of
the soluble metals in ROFA samples from this
source. ROFA (suspended in sterile saline) was
sonicated for 1 min with a Sonifer 450 cell
disruptor (Branson Ultrasonics, Danbury,
CT) before IT instillation.
IT instillation. Male Sprague-Dawley rats
(7–8 weeks of age) were lightly anesthetized
by an intraperitoneal (ip) injection of sodium
methohexitol (Brevital) and instilled with
ROFA (0.1, 0.25, 1, or 2 mg/rat, IT, in a
300 µL sterile saline suspension) according to
the method of Brain et al. (1976). Rats in the
vehicle control group were IT dosed with
300 µL sterile saline. Rats in the particle con-
trol group were dosed with titanium dioxide
(0.25 mg/rat, IT, in a 300 µL sterile saline
suspension). The higher ROFA doses chosen
for these experiments (1 mg and 2 mg) have
been previously shown to produce signiﬁcant
pulmonary inflammation (Antonini et al.
2002) and fall within the range of concentra-
tions consistently used in other animal studies
evaluating pulmonary responses to ROFA
(Antonini et al. 2002; Dreher et al. 1997;
Gavett et al. 1997; Kodavanti et al. 1998).
After IT instillation, all rats were allowed to
recover for 24 hr before subsequent BAL or
intravital microscopy experiments.
Collection of BAL samples and blood for
measurement of systemic and pulmonary
inflammation. Rats were euthanized with
sodium pentobarbital (≥ 100 mg/kg, ip). A
tracheal cannula was inserted, and BAL was
performed through the cannula using ice-cold
Ca2+/Mg2+-free phosphate-buffered saline
(PBS). The ﬁrst lavage was 6 mL and was kept
separate from the rest of the lavage sample.
Subsequent lavages used 8 mL PBS until a
total of 80 mL lavage ﬂuid was collected. The
samples were centrifuged (650 × g, 5 min at
4°C), and the acellular ﬁrst lavage supernatant
(BAL ﬂuid) was aspirated and saved for LDH
activity and albumin protein assays. Cells were
combined, resuspended in HEPES-buffered
medium (10 mM N-[2-hydroxyethyl]piper-
azine-N´-[2-ethanesulfonic acid], 145 mM
NaCl, 5 mM KCl, 1 mM CaCl2, and
5.5 mM D-glucose, pH 7.4) and centrifuged a
second time (650 × g, 5 min, 4°C). The cells
were then resuspended in HEPES-buffered
medium, and cell counts were determined with
an electronic cell counter equipped with a cell-
sizing attachment (Porter et al. 2002). Whole
blood was drawn from a carotid cannula
(inserted for intravital microscopy experiments,
described below) using a Vacutainer blood col-
lection tube with sodium ethylenediamine
tetraacetate as an anticoagulant. Blood cell dif-
ferentials were determined with a Cell-Dyne
3500R hematology cell counter (Abbott
Diagnostics, Abbott Park, IL) (Porter et al.
2001). 
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protein assays. All measurements used for the
current study were made on the day that sam-
ples were taken, and any remaining samples
were frozen for long-term storage (–80°C).
BAL ﬂuid LDH activities were determined as
a marker of cytotoxicity and were measured by
monitoring the LDH catalyzed oxidation of
pyruvate coupled with the reduction of nicoti-
namide adenine dinucleotide at 340 nm using
a commercial assay kit (LDH Reagent; Roche
Diagnostic Systems, Montclair, NJ) and a
Cobas Fara II Analyzer (Roche Diagnostic
Systems), as previously described (Porter et al.
2002). BAL fluid albumin concentrations
were determined as an indicator of the
integrity of the blood–pulmonary epithelial
cell barrier. BAL ﬂuid albumin was measured
colorimetrically at 628 nm based on albumin
binding to bromcresol green using a commer-
cial assay kit (Albumin BCG diagnostic kit;
Sigma Chemical Co., St. Louis, MO) and a
Cobas Fara II Analyzer, as previously described
(Porter et al. 2002).
AM chemiluminescence. AM chemilumi-
nescence was determined as an indicator of
reactive oxygen species production by AM.
The use of unopsonized zymosan in the
chemiluminescence assay allows only AM
chemiluminescence to be measured, because
unopsonized zymosan stimulates AM chemi-
luminescence but not PMNL chemilumines-
cence. The assay was conducted in a total
volume of 0.25 mL HEPES-buffered media.
Resting AM chemiluminescence was deter-
mined by incubating 1.0 × 106 AM/mL at
37°C for 20 min, followed by the addition of
5-amino-2,3-dihydro-1,4-phthalazinedione
(luminol) to a final concentration of
0.08 µg/mL followed by the measurement of
chemiluminescence. To determine zymosan-
stimulated chemiluminescence, unopsonized
zymosan (Sigma) was added to a ﬁnal concen-
tration of 2 mg/mL immediately before the
measurement of chemiluminescence. All
chemiluminescence measurements were made
with an automated luminometer (Autolumat
LB 953; Berthold, Gaithersburg, MD) at
390–620 nm for 15 min. The integral of
counts per minute versus time was calculated.
Zymosan-stimulated chemiluminescence was
calculated as the counts per minute in the
zymosan-stimulated sample minus the counts
per minute in the resting sample. NO-depen-
dent chemiluminescence was determined by
subtracting the zymosan-stimulated chemilu-
minescence from cells pre-incubated with
1 mM 1400W, an inhibitor of NO synthase,
from the zymosan-stimulated chemilumines-
cence from AM without 1400W.
Intravital microscopy. Male Sprague-
Dawley rats (7–8 weeks of age) were anes-
thetized with sodium thiopental (100 mg/kg ip)
and placed on a heating pad to maintain a
37°C rectal temperature. The trachea was intu-
bated to ensure a patent airway, and the right
carotid artery was cannulated to measure arter-
ial pressure. The right spinotrapezius muscle
was then exteriorized for microscopic observa-
tion, leaving its innervation and all feed vessels
intact. After exteriorization, the muscle was
gently secured over an optical pedestal at its
in situ length. The muscle was next enclosed in
a tissue bath for transillumination and observa-
tion. In Sprague-Dawley rats of this age, the
spinotrapezius muscle weighs 285 ± 56 mg
(mean ± SE) and has a surface area of
192±2 8m m 2 (Linderman and Boegehold
1996). Throughout the surgery and subse-
quent experimental period, the muscle was
continuously superfused with an electrolyte
solution (119 mM NaCl, 25 mM NaHCO3,
6 mM KCl, and 3.6 mM CaCl2), warmed to
35°C, and equilibrated with 95% N, 2–5%
CO2 (pH 7.35–7.40). Superfusate flow rate
was maintained at 4–6 mL/min to minimize
equilibration with atmospheric oxygen
(Boegehold and Bohlen 1988).
The animal preparation was then trans-
ferred to the stage of an intravital microscope
coupled to a CCD (charge-coupled device)
video camera. Observations were made with a
20× water immersion objective (final video
image magnification, 1,460×). One to three
microvessels were studied per rat. Video images
were displayed on a high-resolution color video
monitor and videotaped for off-line analysis.
During videotape replay, arteriolar inner diam-
eters were measured with a video caliper
(Cardiovascular Research Institute, Texas
A&M University, College Station, TX), and
venular leukocyte adhesion was monitored.
Experimental protocol 1. In the ﬁrst series
of experiments, arteriolar endothelium-depen-
dent dilation was evaluated in the four ROFA
groups and the saline and TiO2 groups by
assessing the capacity for Ca2+-dependent
endothelial NO formation in response to intra-
luminal infusion of the calcium ionophore
A23187 (Sigma). Glass micropipettes were
beveled to a 23–25° angle and a 2–4 µm inner
tip diameter. One mg of A23187 was dissolved
in 50 µL dimethyl sulfoxide and then serially
diluted in PBS to produce a 10–7 M solution
that was loaded into the micropipettes.
A23187 increases endothelial NO synthase
activity, which produces NO and therefore
relaxes exposed vessels (Schneider et al. 2003).
The micropipette was inserted into the lumen
of the selected arteriole approximately 100 µm
upstream from the diameter measurement site,
and A23187 was then infused directly into the
ﬂow stream. A Picospritzer II pressure system
(General Valve Corporation, Fairﬁeld, NJ) was
used to continuously infuse A23187 for 2-min
periods at net ejection pressures of 5, 10, 20,
and 40 psi. In preliminary tests, we verified
that the amount of agonist ejected from the
pipette tip is directly proportional to the ejec-
tion pressure. The order in which the differ-
ent ejection pressures were applied was
randomized in each experiment, and a 2-min
recovery period followed each ejection. Given
the resistance of the pipette tips, the ﬂuid vol-
umes ejected at these pressures are relatively
small and increase total arteriolar volume ﬂow
by no more than 10% (Nurkiewicz TR,
Boegehold MA, unpublished observations).
At the end of each experiment, adenosine
(ADO) was added via a syringe pump to the
superfusate at a ﬁnal concentration of 10–4 M
to fully dilate the microvascular network and
determine the passive diameter of each arteriole
studied. We have previously shown that the
magnitude of arteriolar dilation induced by
10–4 M ADO is not further augmented by
subsequent exposure to SNP plus nifedipine
in a Ca2+-free superfusate, indicating that
10–4 M ADO completely abolishes arteriolar
tone in the exteriorized spinotrapezius muscle
without altering systemic arterial pressure
(Nurkiewicz and Boegehold 2000).
In a separate series of experiments, the con-
tribution of NO to endothelium-dependent
arteriolar dilation in the spinotrapezius muscle
was evaluated by inhibiting local NO synthesis
with NG-monomethyl-L-arginine (L-NMMA).
Rats in this group of experiments were of the
same age and weight range as those used in
other protocols but did not receive IT saline.
A23187 was infused into arterioles ﬁrst under
the normal superfusate at the four ejection
pressures and again in the presence of
L-NMMA in the superfusate. A syringe pump
was used to continuously infuse L-NMMA at
0.4 mL/min into the superfusate delivery line.
The stock L-NMMA concentration was
adjusted to produce a final superfusate con-
centration of 10–4 M. We have previously
shown that, in this vascular bed after 15 min
of preincubation, L-NMMA at this concentra-
tion maximally inhibits the dilation of spino-
trapezius muscle arterioles to acetylcholine
(Boegehold 1995) and that L-NMMA is a
speciﬁc inhibitor of NO synthesis (Nurkiewicz
and Boegehold 1999).
Experimental protocol 2. To evaluate arte-
riolar responsiveness to NO, the NO donor
SNP was iontophoretically applied to individ-
ual arterioles in rats exposed to either saline or
0.25 mg ROFA. Glass micropipettes were pre-
pared as above and ﬁlled with a 0.05 M solu-
tion of SNP in distilled water. The pipette tip
was placed in light contact with the arteriolar
wall, and a current programmer (model 260;
World Precision Instruments, New Haven,
CT) was used to deliver continuous 2-min
ejection currents of 5, 10 and 20 nA. A recov-
ery period of at least 2 min followed each
application. The order of the 5- and 10-nA
ejection currents was randomized, but the
20-nA ejection current was always performed
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from this stimulus. At the end of each experi-
ment, ADO was added to the superfusate at a
final concentration of 10–4 M to determine
the passive diameter of each arteriole studied.
Experimental protocol 3. Adhering or
rolling leukocytes in ﬁrst-order venules of rats
exposed to either saline or 2 mg ROFA were
quantified to characterize potential micro-
vascular inﬂammation. Leukocytes that were
either stationary or moving but in constant
contact with the venular wall for at least
200 µm were counted for 1 min in each venule
studied.
Data and statistical analysis. Arteriolar
diameter (D, in micrometers) was sampled at
10-sec intervals during all control and infusion
periods. Resting vascular tone was calculated
for each vessel as follows: tone = [(Dpass –
Dc)/Dpass] × 100, where Dpass is passive diame-
ter under ADO and Dc is the diameter mea-
sured during the control period. A tone of
100% represents complete vessel closure,
whereas 0% represents the passive state. For
comparisons of arteriolar responses to A23187
infusion among different treatments and exper-
imental groups, responses were normalized as
follows: percent change from control
=[ ( Dss/Dc) – 1] × 100, where Dss is the steady-
state diameter during A23187 exposure. All
data are reported as mean ± SE. Statistical
analysis was performed by commercially avail-
able software (Sigmastat; SPSS, Chicago, IL).
One-way repeated-measures analysis of variance
(ANOVA) was used to determine the effect of a
treatment within a group or differences among
groups. Two-way repeated measures ANOVA
was used to determine the effects of group,
treatment, and group–treatment interactions
on measured variables. For all ANOVA proce-
dures, the Student-Newman-Keuls method for
post hoc analysis was used to isolate pair wise
differences among speciﬁc groups. Signiﬁcance
was assessed at the 95% confidence level
(p < 0.05) for all tests.
Results
The general characteristics of rats used for
intravital microscopy experiments are reported
in Table 1. At the time of study, mean age,
body weight, and arterial pressure were not
significantly different in the experimental
groups. Rats used for BAL data were of the
same age and body weight as those reported in
Table 1 (data not shown). Resting variables of
all arterioles studied are reported in Table 2.
Resting arteriolar diameters were not signiﬁ-
cantly different among the experimental
groups. Passive diameters (in the presence of
ADO) in the 1-mg ROFA group were signiﬁ-
cantly greater than those in the 0.25-mg TiO2
and 0.25-mg ROFA groups; however, none of
the particle groups was different from saline.
Resting arteriolar tone was not different
among the experimental groups.
The effects of pulmonary exposure to
ROFA on BAL ﬂuid and pulmonary cells are
reported in Table 3. AMs were not signifi-
cantly different in the experimental groups.
However, ROFA exposure did cause dose-
dependent changes in other indicators of pul-
monary inflammation and damage. PMNL
counts were signiﬁcantly elevated in the 1- and
2-mg ROFA groups versus those in the saline
and 0.25-mg TiO2 groups. Additionally,
PMNL counts in the 1- and 2-mg ROFA
groups were signiﬁcantly greater than those in
the 0.25- and 0.1-mg ROFA groups, which
did not differ from either the saline or particle
control (TiO2) groups. BAL ﬂuid albumin was
significantly elevated in the 1- and 2-mg
ROFA groups versus that in the saline and
0.25-mg TiO2 groups. BAL ﬂuid albumin in
the 1- and 2-mg ROFA groups was also signiﬁ-
cantly greater than that in the 0.25- and
0.1-mg ROFA groups, which did not differ
from either the saline or particle control
(TiO2) groups. BAL ﬂuid LDH in the 1- and
2-mg ROFA groups was significantly higher
than that in the saline and 0.25-mg ROFA
groups. BAL ﬂuid LDH in the 1-mg ROFA
group also was signiﬁcantly greater than that
in the 0.25-mg TiO2 group. In three rats (one
exposed to 0.1 mg ROFA and two exposed to
0.25 mg TiO2), insertion of the tracheal can-
nula during BAL caused bleeding that dis-
torted the albumin and LDH data in these
rats. Therefore, BAL fluid data from those
animals were omitted from Table 3. Total
zymosan-stimulated AM chemiluminescence
was significantly greater in the 2-mg ROFA
group than that in the saline, TiO2, 1-mg, or
0.1-mg ROFA groups. NO-dependent AM
chemiluminescence was signiﬁcantly higher in
the 2-mg ROFA group than that in all other
groups.
In spinotrapezius muscle arterioles,
A23187 infusion produced dose-dependent
dilation that was near maximal at the highest
ejection pressure in the IT-saline control
group (Figure 1). This dilation was not an
artifact of ejection pressure because infusion
of the vehicle did not elicit a significant
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Table 1. Proﬁles of experimental animals used for intravital studies (mean ± SE).
Mean arterial 
Experimental group No. of rats Age (days) Weight (g) pressure (mm Hg)
Saline 10 57 ± 4 233 ± 5 88 ± 6
0.25 mg TiO2 3 56 ± 3 219 ± 7 91 ± 15
0.1 mg ROFA 5 51 ± 1 223 ± 7 96 ± 9
0.25 mg ROFA 7 51 ± 3 209 ± 6 80 ± 6
1 mg ROFA 3 52 ± 3 238 ± 17 80 ± 6
2 mg ROFA 6 55 ± 4 218 ± 13 84 ± 5
Table 2. Resting variables for all arterioles studied (mean ± SE).
Experimental group
0.25 mg 0.1 mg 0.25 mg 1 mg 2 mg 
Saline TiO2 ROFA ROFA ROFA ROFA
No. of arterioles 18 8 9 17 8 6
Resting diameter (µm) 43 ± 2 41 ± 2 41 ± 2 41 ± 1 44 ± 2 48 ± 4
Passive diameter (µm) 107 ± 4 100 ± 3 111 ± 6 100 ± 3 117 ± 5* 108 ± 5
Resting tone (percent  59 ± 2 59 ± 2 62 ± 3 59 ± 1 62 ± 2 56 ± 3
of maximum)
*p < 0.05 vs. 0.25 mg TiO2 and 0.25 mg ROFA.
Table 3. BAL data in saline-, TiO2-, and ROFA-exposed rats (mean ± SE).
Cellular content BAL ﬂuid AM (CL)
Experimental group AM PMNL Albumin (mg/mL) LDH (U/L) Total CL NO-dependent CL
Saline 6.20 ± 0.63 1.09 ± 0.12 0.12 ± 0.01 46 ± 5 8.87 ± 1.99 1.44 ± 0.35
0.25 mg TiO2 4.89 ± 0.65 1.11 ± 0.15 0.19 ± 0.02 65 ± 8 3.64 ± 0.73 0.42 ± 0.26
0.1 mg ROFA 5.22 ± 0.93 1.24 ± 0.28 0.20 ± 0.04 75 ± 2* 14.47 ± 2.60 4.40 ± 0.95
0.25 mg ROFA 6.25 ± 0.76 1.91 ± 0.20 0.17 ± 0.01 46 ± 4## 17.42 ± 1.11 5.38 ± 0.20
1 mg ROFA 6.12 ± 0.94 2.87 ± 0.38*,**,#,## 0.46 ± 0.08*,**,#,## 97 ± 9*,**,# 10.47 ± 1.86 3.45 ± 1.01
2 mg ROFA 6.47 ± 0.76 4.02 ± 0.40*,**,#,##,† 0.36 ± 0.04*,**,#,## 84 ± 9*,# 26.26 ± 7.14*,**,##,† 9.81 ± 3.77*,**,#,##,†
CL, chemiluminescence. The number of rats in experimental groups were as follows: 17 for saline, 6 for TiO2, and 5 for all ROFA doses. We evaluated 106 cells/rat for AM and for PMNL.
Total CL and NO-dependent CL were determined as follows: counts per minute × 105/0.25 × 106 AM/15 min.
*p < 0.05 vs. saline. **p < 0.05 vs. TiO2. #p < 0.05 vs. 0.25 mg ROFA. ##p < 0.05 vs. 0.1 mg ROFA. †p < 0.05 vs. 1 mg ROFA.vasoactive response at any of the ejection pres-
sures used in this study.
IT treatment of rats with 0.25 mg or 1 mg
ROFA completely inhibited A23187-induced
dilation of spinotrapezius muscle arterioles
(Figure 2). Arterioles in rats exposed to 2 mg
ROFA also failed to respond to A23187 infu-
sion (data omitted from Figure 2 for clarity).
In rats exposed to 0.1 mg ROFA, A23187
infusion produced an intermediate dilation at
20 and 40 psi that was significantly greater
than that observed in rats exposed to 0.25 mg,
1 mg, or 2 mg ROFA but was less than that in
IT-saline control rats. Therefore, pulmonary
exposure to ROFA inhibited systemic
microvascular function in a dose-dependent
manner.
To determine if the inhibition of systemic
vasodilation after pulmonary exposure to
ROFA was substance specific, arteriolar
responses to A23187 after IT instillation of a
noninﬂammatory particle (TiO2) were evalu-
ated. A23187 infusion had no effect on arterio-
lar diameter in rats exposed to 0.25 mg TiO2
(Figure 3). The arteriolar responses to A23187
infusion between rats exposed to 0.25 mg
ROFA and 0.25 mg TiO2 were not different.
Therefore, inhibition of systemic microvascular
function in response to pulmonary PM expo-
sure does not appear to depend on the pul-
monary toxicity of the particle.
In Figure 4, the effect of A23187 infusion
on arteriolar diameter is expressed in terms of
percent change from control. A comparison is
made between arteriolar responses under the
normal superfusate, during L-NMMA superfu-
sion, and in rats exposed to 0.25 mg ROFA.
The normal superfusate and L-NMMA data
shown here were previously collected from
spinotrapezius muscle ﬁrst-order arterioles in
Sprague-Dawley rats of the same age and
weight range as those used in the present study
but did not receive IT saline (Nurkiewicz and
Boegehold 2004). During L-NMMA super-
fusion, arteriolar dilation in response to
A23187 was significantly decreased at each
ejection pressure, indicating that > 50% of the
arteriolar dilation due to A23187 infusion is
NO dependent. The residual response to
A23187 that persists in the presence of
L-NMMA is NO independent. In rats exposed
to 0.25 mg ROFA, arteriolar responses to
A23187 at 10, 20, and 40 psi were signiﬁcantly
less than those responses observed during
superfusion with L-NMMA. Thus, IT expo-
sure to ROFA inhibits both NO-dependent
and NO-independent components of A23187-
induced dilation of systemic arterioles.
Figure 5 displays arteriolar responsiveness
to iontophoretically applied SNP in rats
exposed to either saline or 0.25 mg ROFA.
The arteriolar responses to SNP at each current
dose represent signiﬁcant dilations from con-
trol diameter and were dose dependent. The
arteriolar responses to SNP in the IT-saline
control group and ROFA group were not dif-
ferent at any current dose. Thus, pulmonary
exposure to ROFA did not alter the respon-
siveness of arteriolar smooth muscle to the
dilator effects of NO.
Microvascular leukocyte activity in the
spinotrapezius muscle is characterized in
Figure 6. Such characterization involved moni-
toring the number of adhering and rolling
leukocytes in venules that were closely paired
to the arterioles of interest. Figure 6A shows a
representative venule in a saline-treated rat.
Figure 6B shows a representative venule in a
rat exposed to 2 mg ROFA, where an increased
leukocyte presence is clearly visible. Figure 6C
indicates that leukocyte adherence and rolling
was 4-fold greater in venules of ROFA-
exposed rats than in saline-treated rats. This
result is consistent with a local inﬂammatory
response at the systemic microvascular level.
Figure 6D indicates that systemic leukocyte
concentrations were not different between
ROFA-exposed and saline-treated rats.
Discussion
To our knowledge, this is the first study to
demonstrate a signiﬁcant effect of acute pul-
monary PM exposure at the systemic micro-
vascular level. There are four prominent
observations within this study.
First, pulmonary PM exposure signifi-
cantly impairs A23187-induced arteriolar
endothelium-dependent dilation in the rat
spinotrapezius muscle (Figures 2 and 3). In
saline-treated rats, this microvascular response
to intraluminal infusion of A23187 was dose
dependent and near the maximal level of
dilation. Resting arteriolar diameter was
unchanged after ROFA or TiO2 exposure
(Table 2). However, A23187-induced arteriolar
endothelium-dependent dilation was either
significantly impaired or abolished after
ROFA or TiO2 exposure. A profound result
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Figure 1. Intraluminal A23187 infusion produces
graded, near-maximal arteriolar dilation in rats
exposed to IT saline; the vehicle is not inherently
vasoactive. Values are mean ± SE. For A23187
infusion, n (number of arterioles studied) = 10; for
vehicle infusion, n = 7. 
*p < 0.05 vs. vehicle at the same ejection pressure.
**p < 0.05 vs. 5 psi response. #p < 0.05 vs. 10 psi response.
##p < 0.05 vs. 20 psi response.
Figure 2. ROFA exposure impairs or abolishes
spinotrapezius muscle arteriolar responsiveness to
intraluminal A23187. Values are mean ± SE. For
saline control, n (number of arterioles studied) = 10;
for 0.1 mg ROFA, n = 9; for 0.25 mg ROFA, n = 8; for
1 mg ROFA, n =8 .
*p < 0.05 vs. 0.25 mg ROFA. **p < 0.05 vs. 0.1, 0.25, and
1 mg ROFA. #p < 0.05 vs. 0.25 mg and 1 mg ROFA.
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Figure 3. TiO2 exposure abolishes spinotrapezius
muscle arteriolar responsiveness to intraluminal
A23187. Values are mean ± SE. For saline control, n
(number of arterioles studied) = 10; for 0.25 mg TiO2,
n = 8; for 0.25 mg ROFA, n = 8. 
*p < 0.05 vs. 0.25 mg TiO2 and 0.25 mg ROFA.
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Figure 4. ROFA exposure impairs both NO-depen-
dent and NO-independent arteriolar responsiveness
to intraluminal A23187 in the spinotrapezius muscle.
NO synthase was competitively inhibited by simulta-
neous superfusion with L-NMMA (10–4 M final
superfusate concentration). Values are mean ± SE.
For normal superfusate and with L-NMMA, n (num-
ber of arterioles studied) = 8; for 0.25 mg ROFA, n = 8.
*p < 0.05 vs. normal superfusate. **p < 0.05 vs. 5 psi
response. #p < 0.05 vs. +L-NMMA. ##p < 0.05 vs. 10 psi
response. †p < 0.05 vs. 20 psi response.
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†of this study is that, despite our ﬁnding that
ROFA or TiO2 exposure at 0.25 mg/rat did
not cause signiﬁcant pulmonary inﬂammation
or damage (as judged by BAL PMNL inﬂux,
BAL albumin, and LDH release; Table 3),
complete impairment of systemic A23187-
induced endothelium-dependent arteriolar
dilation was observed.
Second, pulmonary PM exposure appears
to abolish both NO-dependent and NO-inde-
pendent systemic arteriolar dilation (Figure 4).
In the spinotrapezius muscle of the normal rat,
NO synthase inhibition reduced the effect of
intraluminal A23187 infusion by approxi-
mately 50% (open bars vs. black bars). The
remaining responsiveness to A23187 may be
due to a variety of NO-independent factors
such as bradykinin, cyclooxygenase products,
or ADO. Because the arteriolar response to
intraluminal A23187 infusion after ROFA
exposure is signiﬁcantly less than that during
L-NMMA superfusion in normal rats (blue
bars vs. black bars), it appears that ROFA has
the capacity to impair both NO-dependent
and NO-independent arteriolar dilation.
Third, pulmonary PM exposure does not
affect systemic arteriolar smooth muscle
responsiveness to NO (Figure 5). Regardless
of the iontophoretic ejection current, SNP
applied to the arteriolar wall produced equiva-
lent arteriolar dilation in both ROFA-exposed
and saline-treated control rats. This ﬁnding is
essential because it is impossible to character-
ize the adverse endothelial effects of PM expo-
sure if the microvascular smooth muscle
sensitivity to NO is not clearly deﬁned.
Fourth, PM exposure increases the num-
ber of adhering and rolling leukocytes in
spinotrapezius muscle venules (Figure 6).
This signiﬁcant increase in observable venular
leukocytes (Figure 6C) could be due to a)a n
increased systemic leukocyte concentration
and/or b) an increase in the adhesion activity
between leukocytes and the venular endothe-
lium. We did not observe a difference in the
systemic leukocyte concentrations between
ROFA-exposed and saline-treated control rats
(Figure 6D). However, it is conceivable that
the increase in venular leukocyte adhesion
after ROFA exposure is sufﬁcient to lower free
circulating leukocytes, thereby preventing an
accurate measurement of systemic leukocytes.
This may account for the similar systemic
leukocyte concentrations between saline-
treated and ROFA-exposed rats.
Few studies have investigated the effect of
acute PM exposure on vascular function.
Inhalation of concentrated ambient particles
(CAPs) and ozone in humans causes constric-
tion of the brachial artery but has no effect on
endothelium-dependent or -independent dila-
tion (Brook et al. 2002). Our finding that
endothelium-independent dilation is unaltered
(Figure 5) after PM exposure is in agreement
with Brook et al. (2002), but we did not
observe an effect of PM exposure on resting
arteriolar diameter (Table 2). However,
because vascular tone reflects an integrated
response to a variety of signals that vary in
importance among vascular beds (Cornelissen
et al. 2002; Hill et al. 2001; Zweifach 1991),
our finding that arteriolar tone is unaltered
after PM exposure is not necessarily at odds
with the observations of Brook et al. (2002).
Using ﬂow-dependent dilation as an indirect
index of endothelial function, Brook et al.
(2002) found no effect of CAPs on endothe-
lium-dependent dilation. In contrast, we deliv-
ered an agonist directly to the endothelium of a
single arteriolar segment and found that
endothelium-dependent dilation was potently
impaired after PM exposure (Figures 2–4). A
possible explanation for this discrepancy is that
ﬂow-dependent dilation activates endothelial
NO synthase substantially through a Ca2+-
independent pathway (Muller et al. 1999), but
A23187 does so via a Ca2+-dependent pathway
(Schneider et al. 2003). Additionally, the tech-
nique used to induce ﬂow-dependent dilation
(total flow stoppage by inflation of a cuff
around the proximal forearm and subsequent
release) would likely disturb the local environ-
ment, and the inﬂuence of local metabolites or
myogenic activity under these conditions can-
not be ruled out. The type of PM and expo-
sure methods may also contribute to the
discrepancies between our ﬁndings and those
of Brook et al. (2002).
In vitro treatment of rat aortic rings and
small arteries with PM stimulates vascular
smooth muscle relaxation (Bagate et al. 2004;
Knaapen et al. 2001). In these studies, the ves-
sel segments were precontracted with phenyl-
ephrine and then exposed to a PM solution.
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Figure 5. ROFA exposure does not alter spino-
trapezius muscle arteriolar responsiveness to SNP.
Values are mean ± SE. For saline control, n (number
of arterioles studied) = 8; for 0.25 mg ROFA, n =9 .
*p < 0.05 vs. 0 nA in both groups. **p < 0.05 vs. 10 nA in
both groups.
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Figure 6. ROFA exposure increases venular leukocyte rolling and adhesion in the spinotrapezius muscle.
Abbreviations: n, number of venules studied; N, number of rats studied. (A) Representative venule in an
IT-saline control rat. (B) Representative venule in a rat exposed to 2 mg ROFA. (C) Rolling and adhering
venular leukocytes observed per minute in a 200-µm segment [for IT-saline control, n = 15; for 2 mg ROFA,
n = 15]. (D) Systemic leukocyte concentration in saline control rats (N = 3) and rats exposed to 2 mg ROFA
(N = 3). Values in (C) and (D) are mean ± SE.
*p < 0.05 vs. IT-saline control. 
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BPM exposure in this preparation induced a
dose-dependent relaxation that was partially
endothelium dependent. The tissue isolation
required for in vitro experiments precludes any
neural, local, physical, and/or hormonal inﬂu-
ence on vascular physiology. In vitro observa-
tions on tissues exposed to PM may be of
limited relevance because they mandate a
direct interaction between PM and the sys-
temic vasculature. In support of this possibility,
PM has been reported to enter the systemic cir-
culation. PM deposition in the arteriolar wall
has been documented in stray Mexico City
canines (Calderon-Garciduenas et al. 2001).
Inhaled ultrafine 13C particles have been
shown to translocate to extrapulmonary organs
(Oberdorster et al. 2002). In contrast, studies
with ultraﬁne 192Ir indicate that only a small
fraction of inhaled ultraﬁne PM exits the lung
(Kreyling et al. 2002).
Circulating leukocytes and platelets are
known to increase after PM exposure (Salvi
et al. 1999; Tan et al. 2000; Terashima et al.
1997). Up-regulation of bronchial adhesion
molecules, such as ICAM-1 and VCAM-1,
has also been documented after PM exposure
(Salvi et al. 1999). However, the state of sys-
temic microvascular adhesion molecules after
PM exposure is unknown. Our observations
that venular leukocyte adhesion and rolling are
increased despite no change in the systemic
leukocyte concentration after PM exposure
(Figure 6) suggest that systemic adhesion mol-
ecules are up-regulated and/or activated. NO
plays a vital role in protecting the endothelium
from potential injury, as well as preventing
inflammatory responses and atherosclerosis
development (Cannon 1998). A loss of
endothelial NO production could contribute
to the altered venular leukocyte dynamics after
PM exposure shown in Figure 6.
Tissue blood flow depends primarily on
perfusion pressure and the caliber of resistance
vessels. Changes in caliber are dictated by
chemical and physical stimuli that originate
within the immediate environment of resis-
tance vessels and by changes in neural activity
and circulating humoral agents (Shepherd
1983). Diminished tissue perfusion will dis-
turb the local environment, most notably in
the form of tissue hypoxia. Compensatory
mechanisms, such as arteriolar dilation,
attempt to restore normal tissue perfusion and
therefore normoxia. Low arteriolar wall PO2
(partial pressure of O2) may serve as a stimulus
for the release of endothelium-derived NO
(Sauls and Boegehold 2000), which would
dilate arterioles in an attempt to restore wall
PO2. Typical responses such as these con-
tribute to the maintenance of cardiovascular
homeostasis under normal conditions.
However, in diseased states such as hyper-
cholesterolemia, hypertension, and coronary
artery disease, endothelium-dependent dilation
is often compromised (Drexler and Hornig
1999). If these populations respond to PM
exposure as reported here, the impairment of
endothelium-dependent dilation would com-
promise an already reduced vasodilator reserve,
if not obliterate it, and may precipitate a
cardiovascular incident.
In the present investigation, pulmonary
exposure was accomplished by a single IT
instillation of saline, ROFA, or TiO2. Some
have questioned the relevance of such an
exposure to the human condition of a contin-
uous exposure by inhalation. A review spon-
sored by the Inhalation Specialty Section of
the Society of Toxicology has addressed this
issue (Henderson et al. 1995). Results indi-
cate that pulmonary responses to particle
exposure via inhalation versus IT instillation
correlate well when lung burdens are equiva-
lent. Additionally, our laboratory has shown
that adverse response, that is, enhanced sus-
ceptibility to bacterial infection, is well dis-
tributed throughout the different regions of
the lung after IT instillation of ROFA
(Roberts et al. 2004). In light of such results,
IT instillation has been judged as a useful
exposure method for hazard identification
and elucidation of mechanisms of toxic
responses (Henderson et al. 1995).
Toxic pulmonary responses to ROFA have
been linked to the high concentrations of solu-
ble metals associated with these particles
(Antonini et al. 2002; Dreher et al. 1997). In
addition, ROFA particles are acidic, having a
pH of approximately 4.1 suspended in saline.
For these reasons, some have questioned
whether ROFA particles are a good enough
surrogate for ambient PM. Data from the pre-
sent study indicate that pulmonary exposure to
ROFA or TiO2 resulted in similar alterations
of systemic microvascular function. These
results argue against soluble metals being a
prime factor in this response. Additionally, IT
instillation of acidic saline solutions did not
reproduce the pulmonary effects of ROFA
(data not shown). Therefore, the effects of pul-
monary exposure to ROFA on systemic
microvascular function may be generalized to
ambient PM.
In the present study, a signiﬁcant impair-
ment of systemic arteriolar dilation was
observed 24 hr after IT instillation of 0.1 mg
ROFA (Figure 2). How would this lung bur-
den compare with that of humans exposed to
ambient air? The current U.S. Environmental
Protection Agency limit for ambient PM is
150 µg/m3 (U.S. EPA 1987). Levels in prob-
lem cities on high pollution days can easily
exceed this limit by 3-fold. Assuming
that a) the resting minute ventilation of
7.5 L/min means that 10.8 m3 of air is inhaled
over a 24-hr period; b) 25% of inhaled PM
with a mean diameter of approximately 2 µm
would be deposited in the respiratory zone;
and c) the alveolar surface area of humans is
250 times that of rats, pulmonary exposures in
this study would exceed human exposures to
ambient PM by 20-fold. Considering that spe-
cial populations (i.e., the elderly and those with
preexisting cardiovascular disease) exhibit
increased susceptibility to PM, the results
reported here using young healthy rats may be
relevant.
Conclusions
This study has identiﬁed signiﬁcant effects of
pulmonary PM exposure on the systemic
microcirculation, which is the primary site of
total peripheral resistance, tissue blood ﬂow reg-
ulation, and plasma–tissue exchange. PM expo-
sure studies in large conduit arteries are
important, but the substantial anatomical and
functional differences that exist between con-
duit arteries and arterioles preclude extrapola-
tion of those ﬁndings to the microvascular level.
Microvascular dysfunction is associated with
essentially all cardiovascular diseases and is
among the first targets of inflammatory and
immune responses. Therefore, this study is a
crucial and fundamental ﬁrst step in identifying
the mechanisms by which pulmonary PM
exposure may increase morbidity and mortality.
Results of the present study argue strongly for
future investigations to a) identify the “no
effect” lung burdens for ROFA and TiO2 for
impairment of endothelium-dependent arterio-
lar dilation; b) determine what characteristics of
ROFA are responsible for the impaired
endothelium-dependent arteriolar dilation
observed herein; c) determine the time course of
microvascular effects after PM exposure;
d) determine if other types of PM also elicit the
same effect on the microvascular endothelium;
and e) determine to what degree these observa-
tions are altered by age or pathologic states,
such as hypertension, hypercholesterolemia,
and diabetes, where microvascular structure and
function are already compromised.
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